Sertraline or placebo in chronic breathlessness? Lessons from placebo research by Pattinson, K, Wanigasekera, V

Imaging opioid analgesia in the human brain and its potential relevance for understanding opioid use in chronic pain. by Lee, M, Wanigasekera, V, Tracey, I

Neural correlates of an injury-free model of central sensitization induced by opioid withdrawal in humans. by Wanigasekera, V, Lee, M, Rogers, R, Hu, P, Tracey, I

Opioids for breathlessness: Psychological and neural factors influencing response variability by Abdallah, S, Faull, O, Wanigasekera, V, Finnegan, S, Jensen, D, Pattinson, K

Effects of propofol and thiopentone, and benzodiazepine premedication on heart rate variability measured by spectral analysis. by Howell, S, Wanigasekera, V, Young, J, Gavaghan, D, Sear, J, Garrard, C

Baseline reward circuitry activity and trait reward responsiveness predict expression of opioid analgesia in healthy subjects. by Wanigasekera, V, Lee, M, Rogers, R, Kong, Y, Leknes, S, Andersson, J, Tracey, I

Stimulus site and modality dependence of functional activity within the human spinal cord. by Brooks, J, Kong, Y, Lee, M, Warnaby, C, Wanigasekera, V, Jenkinson, M, Tracey, I

Central sensitisation in knee osteoarthritis: Relating presurgical brainstem neuroimaging and PainDETECT-based patient stratification to arthroplasty outcome by Soni, A, Wanigasekera, V, Mezue, M, Cooper, C, Javaid, M, Price, A, Tracey, I

The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. by Bingel, U, Wanigasekera, V, Wiech, K, Ni Mhuircheartaigh, R, Lee, M, Ploner, M, Tracey, I

Amygdala activity contributes to the dissociative effect of cannabis on pain perception. by Lee, M, Ploner, M, Wiech, K, Bingel, U, Wanigasekera, V, Brooks, J, Menon, D, Tracey, I

Hippocampus mediates nocebo impairment of opioid analgesia through changes in functional connectivity by Bingel, U, Wiech, K, Ritter, C, Wanigasekera, V, Mhuircheartaigh, R, Lee, MC, Ploner, M, Tracey, I

Opioid suppression of conditioned anticipatory brain responses to breathlessness. by Hayen, A, Wanigasekera, V, Faull, O, Campbell, S, Garry, P, Raby, S, Robertson, J, Webster, R, Wise, R, Herigstad, M, Pattinson, K

Response to "treating patients rather than their functional neuroimages" (Br J Anaesth 2018; 121: 969-71) by Wanigasekera, V, Wartolowska, K, Huggins, J, Duff, E, Vennart, W, Whitlock, M, Massat, N, Pauer, L, Rogers, P, Hoggart, B, Tracey, I

Disambiguating pharmacological mechanisms from placebo in neuropathic pain using functional neuroimaging by Wanigasekera, V, Wartolowska, K, Huggins, J, Duff, E, Vennart, W, Whitlock, M, Massat, N, Pauer, L, Rogers, P, Hoggart, B, Tracey, I

Disambiguating pharmacological mechanisms from placebo in neuropathic pain using functional neuroimaging by Wanigasekera, V, Wartolowska, K, Huggins, J, Duff, E, Vennart, W, Whitlock, M, Massat, N, Pauer, L, Rogers, P, Hoggart, B, Tracey, I

What should clinicians tell patients about placebo and nocebo effects? Practical considerations based on expert consensus by Evers, AWM, Colloca, L, Blease, C, Gaab, J, Jensen, KB, Atlas, LY, Beedie, CJ, Benedetti, F, Bingel, U, Büchel, C, Bussemaker, J, Colagiuri, B, Crum, AJ, Finniss, DG, Geers, AL, Howick, J, Klinger, R, Meeuwis, SH, Meissner, K, Napadow, V, Petrie, KJ, Rief, W, Smeets, I, Wager, TD, Wanigasekera, V, Vase, L, Kelley, JM, Kirsch, I, Consortium of Placebo Experts